Asset type Foreign Equity Sector

KODEX SYNTH-US Biotech(185680)

The most effective way to invest in the fast-growing industry, Biotechnology. KODEX Synth-US bio mainly focuses on USA's biotechnology companies committed to healthier future.

  • Current Price


    down 790 (-3.66%)

  • iNAV


    down 578 (-2.69%)

  • Trading Volume


* Last data obtained
Quotes delayed at least 20 minutes.Market data provided by KOSCOM.

*as of

Benchmark Index

S&P Biotechnology Select Industry Index(KRW)

The S&P Biotechnology Select Sector Index seeks to track the Biotechnology sector - stock classifications are based on the Global Industry Classification Standard (GICS).

View index information in detail
Key Facts
  • Net Assets
    11 (billion)
  • Inception Date
    October 31, 2013
  • Gross Expense
    (AP : 0.020%, Manager fee : 0.190%, Trustee Fee : 0.020%, General Administrator Fee : 0.020%)
  • Dividend
    No dividend distribution
  • Base Currency
  • General
    Shinhan Aitas
  • Trustee
    KB Bank
  • Related
  • Carefully consider the Funds' investment objectives, risk factors, and charges and expenses before investing.
  • Collective investment schemes are not insured by the Korea Deposit Insurance Corporation.
  • The performance quoted represents past performance and does not guarantee future results.
  • Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold.
  • Current performance may be lower or higher than the performance quoted.
  • This information is not warranted to be accurate, complete, or timely.
  • Neither KOSCOM nor Samsung Asset Management is responsible for any damages or losses arising from any use of the information on this website.
  • This website is made in the Korean language, and if there shall arise any conflict between the Korean version and any translation thereof, including this -English translation, the Korean version shall prevail.